Upfront consolidation treatment with 131 I‐mIbG followed by myeloablative chemotherapy and hematopoietic stem cell transplantation in high‐risk neuroblastoma-Reference-Cited by-同舟云学术

Upfront consolidation treatment with 131 I‐mIbG followed by myeloablative chemotherapy and hematopoietic stem cell transplantation in high‐risk neuroblastoma

Published:2020-09 Issue:3 Volume:4 Page:168-177
ISSN:2574-2272
Container-title:Pediatric Investigation
language:en
Short-container-title:Pediatr. Invest.

Author:

Feng Jianhua¹²,Cheng Frankie WT³,Leung Alex WK¹,Lee Vincent³,Yeung Eva WM⁴,Ching Lam Hoi⁴,Cheung Jeanny³,Lam Grace KS³,Chow Terry TW³,Yan Carol LS³,Kong Li Chi¹³

Affiliation:

1. Department of Paediatrics The Chinese University of Hong Kong Hong Kong China

2. Department of Paediatrics The First Affiliated Hospital of Wenzhou Medical University Wenzhou China

3. Department of Paediatrics and Adolescent Medicine Hong Kong Children’s Hospital Hong Kong China

4. Department of Clinical Oncology Prince of Wales Hospital The Chinese University of Hong Kong Hong Kong China

Publisher

Wiley

Subject

Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ped4.12216

Reference48 articles.

1. Neuroblastoma

2. Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study

3. Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation: a report from the European Bone Marrow Transplantation Solid Tumor Registry.

4. Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial

5. Role of radiotherapy dose‐escalation for high‐risk neuroblastoma with post‐surgical primary site gross residual disease: A report from the COG ANBL0532 Study;Liu K;Int J Radiat Oncol * Biol * Phys,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Timing and chemotherapy association for 131-I-MIBG treatment in high-risk neuroblastoma;Biochemical Pharmacology;2023-10

2. Synchronous occurrence of neuroblastic tumour and exocrine carcinoma of the pancreas in a child;Pathology;2023-10

3. Phase II study of ¹³¹I‐metaiodobenzylguanidine with 5 days of topotecan for refractory or relapsed neuroblastoma: Results of the French study MIITOP;Pediatric Blood & Cancer;2023-08-13

4. Prognostic value of texture analysis of the primary tumour in high‐risk neuroblastoma: An ¹⁸ F‐DOPA PET study;Pediatric Blood & Cancer;2022-08-03

5. The impact of response to induction chemotherapy on the event-free and overall survival in patients with high-risk neuroblastoma: a systematic review and meta-analysis;Pediatric Hematology/Oncology and Immunopathology;2022-06-25